Table 2:

Summary of the included patients in each group, duration of follow up and outcomes:

			On Clopidogrel	95% CI On Clopidogrel	Off Clopidogrel	95% CI Off Clopidogrel	p-value
		Aggressive Medical Management alone arm
No. Patients			50		158
Duration of follow-up in months, median (IQR)			36		33
Primary endpoint,* n (%)			3 (6.0%)	1.3–16.5	17 (10.8%)	6.4–16.7	0.31†
Major hemorrhage, n (%)			2 (4.0%)	0.5–13.7	4 (2.5%)	0.7–6.4	0.67†
		Percutaneous Transluminal Angioplasty and Stenting arm
No. Patients			46		143
Duration of follow-up in months, median (IQR)			34		36
Primary endpoint,* n (%)			4 (8.7%)	2.4–20.8	14 (9.8%)	5.5–15.9	0.82†
Major hemorrhage, n (%)			5 (10.9%)	3.6–23.6	5 (3.5%)	1.1–8.0	0.08†

^*ischemic stroke in the territory or any stroke or death within 30 days after revascularization during follow-up

^†logrank test